|
1
|
Myal Y, Leygue E and Blanchard AA: Claudin
1 in breast tumorigenesis: Revelation of a possible novel ‘claudin
high’ subset of breast cancers. J Biomed Biotechnol.
2010:9568972010. View Article : Google Scholar
|
|
2
|
Singh AB, Sharma A and Dhawan P: Claudin
family of proteins and cancer: An overview. J Oncol.
2010:5419572010. View Article : Google Scholar
|
|
3
|
Tsukita S, Furuse M and Itoh M:
Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol.
2:285–293. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matter K and Balda MS: Signalling to and
from tight junctions. Nat Rev Mol Cell Biol. 4:225–236. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Furuse M and Tsukita S: Claudins in
occluding junctions of humans and flies. Trends Cell Biol.
16:181–188. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Van Itallie CM and Anderson JM: Claudins
and epithelial para-cellular transport. Annu Rev Physiol.
68:403–429. 2006. View Article : Google Scholar
|
|
7
|
Morin PJ: Claudin proteins in human
cancer: Promising new targets for diagnosis and therapy. Cancer
Res. 65:9603–9606. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Soini Y: Expression of claudins 1, 2, 3,
4, 5 and 7 in various types of tumours. Histopathology. 46:551–560.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sakaguchi T, Suzuki S, Higashi H, Inaba K,
Nakamura S, Baba S, Kato T and Konno H: Expression of tight
junction protein claudin-5 in tumor vessels and sinusoidal
endothelium in patients with hepatocellular carcinoma. J Surg Res.
147:123–131. 2008. View Article : Google Scholar
|
|
10
|
Escudero-Esparza A, Jiang WG and Martin
TA: The Claudin family and its role in cancer and metastasis. Front
Biosci. 16:1069–1083. 2011. View
Article : Google Scholar
|
|
11
|
Boireau S, Buchert M, Samuel MS, Pannequin
J, Ryan JL, Choquet A, Chapuis H, Rebillard X, Avancès C, Ernst M,
et al: DNA-methylation-dependent alterations of claudin-4
expression in human bladder carcinoma. Carcinogenesis. 28:246–258.
2007. View Article : Google Scholar
|
|
12
|
Liu Y, Sun W, Zhang K, Zheng H, Ma Y, Lin
D, Zhang X, Feng L, Lei W, Zhang Z, et al: Identification of genes
differentially expressed in human primary lung squamous cell
carcinoma. Lung Cancer. 56:307–317. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Paschoud S, Bongiovanni M, Pache JC and
Citi S: Claudin-1 and claudin-5 expression patterns differentiate
lung squamous cell carcinomas from adenocarcinomas. Mod Pathol.
20:947–954. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Resnick MB, Konkin T, Routhier J, Sabo E
and Pricolo VE: Claudin-1 is a strong prognostic indicator in stage
II colonic cancer: A tissue microarray study. Mod Pathol.
18:511–518. 2005. View Article : Google Scholar
|
|
15
|
Morohashi S, Kusumi T, Sato F, Odagiri H,
Chiba H, Yoshihara S, Hakamada K, Sasaki M and Kijima H: Decreased
expression of claudin-1 correlates with recurrence status in breast
cancer. Int J Mol Med. 20:139–143. 2007.PubMed/NCBI
|
|
16
|
Blanchard AA, Skliris GP, Watson PH,
Murphy LC, Penner C, Tomes L, Young TL, Leygue E and Myal Y:
Claudins 1, 3, and 4 protein expression in ER negative breast
cancer correlates with markers of the basal phenotype. Virchows
Arch. 454:647–656. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Osanai M, Murata M, Chiba H, Kojima T and
Sawada N: Epigenetic silencing of claudin-6 promotes
anchorage-independent growth of breast carcinoma cells. Cancer Sci.
98:1557–1562. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lanigan F, McKiernan E, Brennan DJ,
Hegarty S, Millikan RC, McBryan J, Jirstrom K, Landberg G, Martin
F, Duffy MJ, et al: Increased claudin-4 expression is associated
with poor prognosis and high tumour grade in breast cancer. Int J
Cancer. 124:2088–2097. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kolokytha P, Yiannou P, Keramopoulos D,
Kolokythas A, Nonni A, Patsouris E and Pavlakis K: Claudin-3 and
claudin-4: Distinct prognostic significance in triple-negative and
luminal breast cancer. Appl Immunohistochem Mol Morphol.
22:125–131. 2014. View Article : Google Scholar
|
|
20
|
Szasz AM, Nemeth Z, Gyorffy B, Micsinai M,
Krenacs T, Baranyai Z, Harsanyi L, Kiss A, Schaff Z, Tokes AM, et
al: Identification of a claudin-4 and E-cadherin score to predict
prognosis in breast cancer. Cancer Sci. 102:2248–2254. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kominsky SL, Argani P, Korz D, Evron E,
Raman V, Garrett E, Rein A, Sauter G, Kallioniemi OP and Sukumar S:
Loss of the tight junction protein claudin-7 correlates with
histological grade in both ductal carcinoma in situ and invasive
ductal carcinoma of the breast. Oncogene. 22:2021–2033. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu Q, Liu Y, Ren Y, Xu X, Yu L, Li Y and
Quan C: Tight junction protein, claudin-6, downregulates the
malignant phenotype of breast carcinoma. Eur J Cancer Prev.
19:186–194. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Litkouhi B, Kwong J, Lo CM, Smedley JG
III, McClane BA, Aponte M, Gao Z, Sarno JL, Hinners J, Welch WR, et
al: Claudin-4 overexpression in epithelial ovarian cancer is
associated with hypomethylation and is a potential target for
modulation of tight junction barrier function using a C-terminal
fragment of Clostridium perfringens enterotoxin. Neoplasia.
9:304–314. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Abuazza G, Becker A, Williams SS,
Chakravarty S, Truong HT, Lin F and Baum M: Claudins 6, 9, and 13
are developmentally expressed renal tight junction proteins. Am J
Physiol Renal Physiol. 291:F1132–F1141. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Oliveira SS and Morgado-Díaz JA: Claudins:
Multifunctional players in epithelial tight junctions and their
role in cancer. Cell Mol Life Sci. 64:17–28. 2007. View Article : Google Scholar
|
|
26
|
Lazarevich NL and Fleishman DI:
Tissue-specific transcription factors in progression of epithelial
tumors. Biochemistry. 73:573–591. 2008.PubMed/NCBI
|
|
27
|
Zavala-Zendejas VE, Torres-Martinez AC,
Salas-Morales B, Fortoul TI, Montaño LF and Rendon-Huerta EP:
Claudin-6, 7, or 9 overexpression in the human gastric
adenocarcinoma cell line AGS increases its invasiveness, migration,
and proliferation rate. Cancer Invest. 29:1–11. 2011. View Article : Google Scholar
|
|
28
|
Itoh M, Furuse M, Morita K, Kubota K,
Saitou M and Tsukita S: Direct binding of three tight
junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH
termini of claudins. J Cell Biol. 147:1351–1363. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Balda MS, Garrett MD and Matter K: The
ZO-1-associated Y-box factor ZONAB regulates epithelial cell
proliferation and cell density. J Cell Biol. 160:423–432. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yamamoto Y, Nishimura N, Morimoto S,
Kitamura H, Manabe S, Kanayama HO, Kagawa S and Sasaki T: Distinct
roles of Rab3B and Rab13 in the polarized transport of apical,
basolateral, and tight junctional membrane proteins to the plasma
membrane. Biochem Biophys Res Commun. 308:270–275. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo Y, Xu X, Liu Z, Zhang T, Zhang X, Wang
L, Wang M, Liu Y, Lu Y, Liu Y, et al: Apoptosis signal-regulating
kinase 1 is associated with the effect of claudin-6 in breast
cancer. Diagn Pathol. 7:1112012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Armstrong SM, Wang C, Tigdi J, Si X,
Dumpit C, Charles S, Gamage A, Moraes TJ and Lee WL: Influenza
infects lung microvascular endothelium leading to microvascular
leak: Role of apoptosis and claudin-5. PLoS One. 7:e473232012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Akasaka H, Sato F, Morohashi S, Wu Y, Liu
Y, Kondo J, Odagiri H, Hakamada K and Kijima H: Anti-apoptotic
effect of claudin-1 in tamoxifen-treated human breast cancer MCF-7
cells. BMC Cancer. 10:5482010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Michl P, Barth C, Buchholz M, Lerch MM,
Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Löhr M, et al:
Claudin-4 expression decreases invasiveness and metastatic
potential of pancreatic cancer. Cancer Res. 63:6265–6271.
2003.PubMed/NCBI
|
|
36
|
Agarwal R, D’Souza T and Morin PJ:
Claudin-3 and claudin-4 expression in ovarian epithelial cells
enhances invasion and is associated with increased matrix
metalloproteinase-2 activity. Cancer Res. 65:7378–7385. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hashimi SM, Yu S, Alqurashi N, Ipe DS and
Wei MQ: Immunotoxin-mediated targeting of claudin-4 inhibits the
proliferation of cancer cells. Int J Oncol. 42:1911–1918.
2013.PubMed/NCBI
|
|
38
|
Esteller M: Relevance of DNA methylation
in the management of cancer. Lancet Oncol. 4:351–358. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sato N, Maitra A, Fukushima N, van Heek
NT, Matsubayashi H, Iacobuzio-Donahue CA, Rosty C and Goggins M:
Frequent hypomethylation of multiple genes overexpressed in
pancreatic ductal adenocarcinoma. Cancer Res. 63:4158–4166.
2003.PubMed/NCBI
|
